Terms: = Prostate cancer AND NRG1, ENSG00000157168, 3084, SMDF, NDF, HRGA, HRG1, HGL, GGF2, GGF, ARIA AND Treatment
12 results:
1. Redesign of radiotherapy for prostate cancer: a proposal for universal healthcare systems.
Beck da Silva Etges AP; de Lara LR; Sapper SL; Frankenberg Berger AV; Streck M; Zardo L; Linhares A; Nassif M; Zanotto A; Pereira Lima MN; Vargas R; Polanczyk CA
J Comp Eff Res; 2023 Dec; 12(12):e230023. PubMed ID: 37916706
[No Abstract] [Full Text] [Related]
2. Comprehensive analysis of tumor mutation burden and immune microenvironment in prostate cancer.
Liao J; Ye Y; Xu X
Clin Transl Oncol; 2022 Oct; 24(10):1986-1997. PubMed ID: 35732871
[TBL] [Abstract] [Full Text] [Related]
3. Technical Note: A standardized automation framework for monitoring institutional radiotherapy protocol compliance.
Quirk S; Lovis J; Stenhouse K; Van Dyke L; Roumeliotis M; Thind K
Med Phys; 2021 May; 48(5):2661-2666. PubMed ID: 33619728
[TBL] [Abstract] [Full Text] [Related]
4. Pattern of care in radiotherapy at a University Hospital in Spain: the RENORT project.
López-Torrecilla J; González Sanchis D; Granero Cabañero D; García Miragall E; Almendros Blanco P; Hernandez Machancoses A; Brualla González L; Pastor Peidro J; Gordo Partearroyo JC; Rosello Ferrando J
Clin Transl Oncol; 2021 Aug; 23(8):1657-1665. PubMed ID: 33586123
[TBL] [Abstract] [Full Text] [Related]
5. Identification of tumors with nrg1 rearrangement, including a novel putative pathogenic UNC5D-nrg1 gene fusion in prostate cancer by data-drilling a de-identified tumor database.
Ptáková N; Martínek P; Holubec L; Janovský V; Vančurová J; Grossmann P; Navarro PA; Rodriguez Moreno JF; Alaghehbandan R; Hes O; Májek O; Pešek M; Michal M; Ondič O
Genes Chromosomes Cancer; 2021 Jul; 60(7):474-481. PubMed ID: 33583086
[TBL] [Abstract] [Full Text] [Related]
6. Development of a Radiation Oncology-Specific Prospective Data Registry for Research and Quality Improvement: A Clinical Workflow-Based Solution.
Chen AM; Kupelian PA; Wang PC; Steinberg ML
JCO Clin Cancer Inform; 2018 Dec; 2():1-9. PubMed ID: 30652556
[TBL] [Abstract] [Full Text] [Related]
7. Response to ERBB3-Directed Targeted Therapy in
Drilon A; Somwar R; Mangatt BP; Edgren H; Desmeules P; Ruusulehto A; Smith RS; Delasos L; Vojnic M; Plodkowski AJ; Sabari J; Ng K; Montecalvo J; Chang J; Tai H; Lockwood WW; Martinez V; Riely GJ; Rudin CM; Kris MG; Arcila ME; Matheny C; Benayed R; Rekhtman N; Ladanyi M; Ganji G
Cancer Discov; 2018 Jun; 8(6):686-695. PubMed ID: 29610121
[No Abstract] [Full Text] [Related]
8. Are pitch and roll compensations required in all pathologies? A data analysis of 2945 fractions.
Mancosu P; Reggiori G; Gaudino A; Lobefalo F; Paganini L; Palumbo V; Stravato A; Tomatis S; Scorsetti M
Br J Radiol; 2015; 88(1055):20150468. PubMed ID: 26393283
[TBL] [Abstract] [Full Text] [Related]
9. CD74-nrg1 fusions in lung adenocarcinoma.
Fernandez-Cuesta L; Plenker D; Osada H; Sun R; Menon R; Leenders F; Ortiz-Cuaran S; Peifer M; Bos M; Daßler J; Malchers F; Schöttle J; Vogel W; Dahmen I; Koker M; Ullrich RT; Wright GM; Russell PA; Wainer Z; Solomon B; Brambilla E; Nagy-Mignotte H; Moro-Sibilot D; Brambilla CG; Lantuejoul S; Altmüller J; Becker C; Nürnberg P; Heuckmann JM; Stoelben E; Petersen I; Clement JH; Sänger J; Muscarella LA; la Torre A; Fazio VM; Lahortiga I; Perera T; Ogata S; Parade M; Brehmer D; Vingron M; Heukamp LC; Buettner R; Zander T; Wolf J; Perner S; Ansén S; Haas SA; Yatabe Y; Thomas RK
Cancer Discov; 2014 Apr; 4(4):415-22. PubMed ID: 24469108
[TBL] [Abstract] [Full Text] [Related]
10. Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database.
Hippisley-Cox J; Coupland C
BMJ; 2010 May; 340():c2197. PubMed ID: 20488911
[TBL] [Abstract] [Full Text] [Related]
11. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R
Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304
[TBL] [Abstract] [Full Text] [Related]
12. Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cells.
Bacus SS; Yarden Y; Oren M; Chin DM; Lyass L; Zelnick CR; Kazarov A; Toyofuku W; Gray-Bablin J; Beerli RR; Hynes NE; Nikiforov M; Haffner R; Gudkov A; Keyomarsi K
Oncogene; 1996 Jun; 12(12):2535-47. PubMed ID: 8700512
[TBL] [Abstract] [Full Text] [Related]
